119 related articles for article (PubMed ID: 6697550)
1. Inhibition of pressor responses induced by electrical stimulation of the mesencephalon by vasopressin and oxytocin.
de Jong W; Versteeg CA; Bohus B
Clin Exp Hypertens A; 1984; 6(1-2):139-47. PubMed ID: 6697550
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of centrally-evoked pressor responses by neurohypophyseal peptides and their fragments.
Versteeg CA; Bohus B; de Jong W
Neuropharmacology; 1982 Dec; 21(12):1359-64. PubMed ID: 7155315
[TBL] [Abstract][Full Text] [Related]
3. Attenuation by arginine- and desglycinamide-lysine-vasopressin of a centrally evoked pressor response.
Versteeg CA; Bohus B; de Jong W
J Auton Nerv Syst; 1982 Sep; 6(2):253-62. PubMed ID: 7175086
[TBL] [Abstract][Full Text] [Related]
4. Arginine-vasopressin inhibits centrally induced pressor responses by involving hippocampal mechanisms.
Versteeg CA; De Jong W; Bohus B
Brain Res; 1984 Feb; 292(2):317-26. PubMed ID: 6140991
[TBL] [Abstract][Full Text] [Related]
5. Reduction of a centrally induced pressor response by neurohypophyseal peptides: the involvement of lower brainstem mechanisms.
Versteeg CA; Cransberg K; De Jong W; Bohus B
Eur J Pharmacol; 1983 Oct; 94(1-2):133-40. PubMed ID: 6140170
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and heart rate responses to microinjection of vasopressin into the nucleus tractus solitarius region of the rat.
Matsuguchi H; Sharabi FM; Gordon FJ; Johnson AK; Schmid PG
Neuropharmacology; 1982 Jul; 21(7):687-93. PubMed ID: 7121740
[TBL] [Abstract][Full Text] [Related]
7. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: a comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin.
Vallejo M; Carter DA; Lightman SL
Neurosci Lett; 1984 Dec; 52(3):247-52. PubMed ID: 6521969
[TBL] [Abstract][Full Text] [Related]
9. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
Feuerstein G; Zerbe RL; Faden AI
J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
[TBL] [Abstract][Full Text] [Related]
10. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit.
Martin SM; Malkinson TJ; Veale WL; Pittman QJ
Brain Res; 1985 Nov; 348(1):137-45. PubMed ID: 2933125
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a functional relationship between noradrenaline and neurohypophyseal peptides in the brainstem of rats.
Vallejo M; Lightman SL
Brain Res; 1987 Oct; 422(2):295-302. PubMed ID: 3676790
[TBL] [Abstract][Full Text] [Related]
12. Central cardiovascular effects of mammalian neurohypophyseal peptides in conscious rats.
Zerbe RL; Kirtland S; Faden AI; Feuerstein G
Peptides; 1983; 4(5):627-30. PubMed ID: 6657510
[TBL] [Abstract][Full Text] [Related]
13. Enhanced pressor responses to ICV vasopressin after pretreatment with oxytocin.
Poulin P; Komulainen A; Takahashi Y; Pittman QJ
Am J Physiol; 1994 Feb; 266(2 Pt 2):R592-8. PubMed ID: 8141420
[TBL] [Abstract][Full Text] [Related]
14. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
Shimizu K; Schwartz J; McGrath BP
Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
[TBL] [Abstract][Full Text] [Related]
15. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
Croiset G; De Wied D
Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
[TBL] [Abstract][Full Text] [Related]
16. Central target for the behavioural effects of vasopressin neuropeptides.
de Wied D; Gaffori O; van Ree JM; de Jong W
Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
[TBL] [Abstract][Full Text] [Related]
18. Effects of V2 receptor activity on the pressor response to vasopressin in the rat.
Shimizu K; Schwartz J; McGrath BP
Clin Exp Pharmacol Physiol; 1991 May; 18(5):349-52. PubMed ID: 1829666
[TBL] [Abstract][Full Text] [Related]
19. Central cardiovascular actions of vasopressin in the rat.
Lebrun C; Rohmeiss P; Demmert G; Rettig R; Unger T
Can J Physiol Pharmacol; 1987 Aug; 65(8):1712-6. PubMed ID: 3690394
[TBL] [Abstract][Full Text] [Related]
20. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
Kovács GL; De Wied D
Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
